support_agent

Your contact persons

CHEPLAPHARM Arzneimittel GmbH

View:
format_list_bulleted grid_view

09/12/2023

CHEPLAPHARM opens Swiss subsidiary and wins Agnes Wasem as Managing Director
Press releases
Read more chevron_right

07/27/2023

CHEPLAPHARM successfully closes acquisition of Zyprexa® portfolio
Press releases
Read more chevron_right

04/28/2023

CHEPLAPHARM places notes in a volume of €750m in challenging market environment
Press releases
Read more chevron_right

04/26/2023

Announcement on Pricing
Press releases
Read more chevron_right

04/24/2023

Announcement on Offering
Press releases
Read more chevron_right

04/22/2023

CHEPLAPHARM announces acquisition of Zyprexa® from Lilly
Press releases
Read more chevron_right

03/01/2023

CHEPLAPHARM strengthens portfolio with asthma treatment from AstraZeneca
Press releases
Read more chevron_right

01/23/2023

CHEPLAPHARM continues expansion in China with the acquisition of XELODA® from Roche
Press releases
Read more chevron_right

12/01/2022

Change in the Management of CHEPLAPHARM
Archive
Read more chevron_right

11/29/2022

CHEPLAPHARM remains on growth track
Archive
Read more chevron_right
Back to top expand_less